Michael Mertzman

883 total citations · 1 hit paper
7 papers, 569 citations indexed

About

Michael Mertzman is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Michael Mertzman has authored 7 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Michael Mertzman's work include HIV/AIDS drug development and treatment (3 papers), Hepatitis C virus research (2 papers) and Protein Interaction Studies and Fluorescence Analysis (1 paper). Michael Mertzman is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Hepatitis C virus research (2 papers) and Protein Interaction Studies and Fluorescence Analysis (1 paper). Michael Mertzman collaborates with scholars based in United States. Michael Mertzman's co-authors include William J. Pitts, Thomas E. La Cruz, S. Natarajan, Phil S. Baran, Michael A. Schmidt, Nitin B. Darvatkar, Tian Qin, Ying Jin, Julian C. Lo and Jinghan Gui and has published in prestigious journals such as Science, The Journal of Organic Chemistry and Biopolymers.

In The Last Decade

Michael Mertzman

7 papers receiving 558 citations

Hit Papers

Practical olefin hydroamination with nitroarenes 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mertzman United States 7 467 174 129 22 22 7 569
Kazutaka Ikegashira Japan 11 516 1.1× 44 0.3× 86 0.7× 28 1.3× 52 2.4× 15 652
Robert J. McHugh United States 9 350 0.7× 26 0.1× 153 1.2× 35 1.6× 13 0.6× 12 445
Yuliang Tang China 7 325 0.7× 54 0.3× 122 0.9× 28 1.3× 4 0.2× 11 467
Graeme Barker United Kingdom 15 499 1.1× 121 0.7× 113 0.9× 21 1.0× 3 0.1× 31 617
Tomio Yamakawa Japan 8 255 0.5× 85 0.5× 111 0.9× 16 0.7× 11 0.5× 16 349
Wen‐Biao Wu China 14 622 1.3× 135 0.8× 81 0.6× 106 4.8× 10 0.5× 26 739
Robert H. Lemus United States 8 264 0.6× 43 0.2× 144 1.1× 9 0.4× 24 1.1× 9 429
Mark S. Bednarz United States 11 376 0.8× 152 0.9× 145 1.1× 18 0.8× 1 0.0× 23 477
Suyeal Bae United States 12 381 0.8× 37 0.2× 161 1.2× 16 0.7× 4 0.2× 14 453
Zhongqi Shen United States 15 379 0.8× 90 0.5× 185 1.4× 10 0.5× 19 553

Countries citing papers authored by Michael Mertzman

Since Specialization
Citations

This map shows the geographic impact of Michael Mertzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mertzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mertzman more than expected).

Fields of papers citing papers by Michael Mertzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mertzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mertzman. The network helps show where Michael Mertzman may publish in the future.

Co-authorship network of co-authors of Michael Mertzman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mertzman. A scholar is included among the top collaborators of Michael Mertzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mertzman. Michael Mertzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hart, Amy C., Lynn M. Abell, Junqing Guo, et al.. (2019). Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Medicinal Chemistry Letters. 11(3). 266–271. 31 indexed citations
2.
Gui, Jinghan, Ying Jin, Tian Qin, et al.. (2015). Practical olefin hydroamination with nitroarenes. Science. 348(6237). 886–891. 452 indexed citations breakdown →
3.
Casarez, Anthony, Ruby Cai, Michael O. Clarke, et al.. (2011). Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity. Bioorganic & Medicinal Chemistry Letters. 22(3). 1394–1396. 28 indexed citations
4.
Clarke, Michael O., Xiaowu Chen, Aesop Cho, et al.. (2011). Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease. Bioorganic & Medicinal Chemistry Letters. 21(12). 3568–3572. 18 indexed citations
5.
Fardis, Maria, Michael Mertzman, Thorsten Kirschberg, et al.. (2006). Use of Benzofuran for Concomitant Protection of Aldehyde and Phenol Groups in the Preparation of Mycophenolic Acid Analogues. The Journal of Organic Chemistry. 71(13). 4835–4839. 13 indexed citations
6.
Bogusky, Michael J., Adel M. Naylor, Michael Mertzman, et al.. (1993). The solution conformation Ac‐Pen‐Arg‐Gly‐Asp‐Cys‐OH, a potent fibrinogen receptor antagonist. Biopolymers. 33(8). 1287–1297. 14 indexed citations
7.
Song, Zhiguo J., Michael Mertzman, & David L. Hughes. (1993). Improved synthesis of quinaldines by the skraup reaction. Journal of Heterocyclic Chemistry. 30(1). 17–21. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026